GI
IDYA icon

GAMMA Investing’s IDEAYA Biosciences IDYA Stock Holding History

GAMMA Investing’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$48.2K Sell
1,293
-69
-5% -$2.11K ﹤0.01% 2321
2026
Q1 		$45.4K Buy
1,362
+72
+6% +$2.42K ﹤0.01% 2242
2025
Q4 		$44.6K Buy
1,290
+174
+16% +$5.55K ﹤0.01% 2139
2025
Q3 		$30.4K Buy
1,116
+180
+19% +$4.35K ﹤0.01% 2298
2025
Q2 		$19.7K Buy
936
+501
+115% +$9.61K ﹤0.01% 2469
2025
Q1 		$7.13K Buy
435
+160
+58% +$3.41K ﹤0.01% 2911
2024
Q4 		$7.07K Sell
275
-83
-23% -$2.35K ﹤0.01% 2765
2024
Q3 		$11.3K Buy
358
+228
+175% +$8.65K ﹤0.01% 2403
2024
Q2 		$4.56K Buy
130
+11
+9% +$436 ﹤0.01% 2614
2024
Q1 		$5.22K Buy
119
+36
+43% +$1.55K ﹤0.01% 2393
2023
Q4 		$3.61K Buy
+83
New +$2.48K ﹤0.01% 2371

Other funds holding IDYA

TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
KFP
Kerr Financial Planning Fresno, California $89.6M AUM 72.71% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
CMA
Cedar Mountain Advisors Lake Oswego, Oregon $581M AUM 18.16% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
AFC
Ares Financial Consulting Calabasas, California $139M AUM

GAMMA Investing's IDYA Position: Q2 2026 in Review

GAMMA Investing reduced its IDEAYA Biosciences (IDYA) stake by 5.1% in Q2 2026, selling an estimated $2.11K and leaving 1,293 shares worth $48.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2321.

GAMMA Investing first reported a position in IDYA in Q4 2023 and has held it in 11 quarters since. 16 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • GAMMA Investing held 1,293 shares of IDEAYA Biosciences worth $48.2K as of Q2 2026.
  • GAMMA Investing sold 69 IDEAYA Biosciences shares in Q2 2026, an estimated $2.11K.
  • IDEAYA Biosciences made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #2321 holding.
  • GAMMA Investing first reported a position in IDEAYA Biosciences in Q4 2023 and has held it in 11 quarters since.
  • 16 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.